Aptamer Sciences Inc (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 990.00
-32.00 (-3.13%)
At close: Oct 30, 2025
Aptamer Sciences Company Description
Aptamer Sciences Inc, a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms.
The company’s platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders.
It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer.
Aptamer Sciences Inc was founded in 2011 and is headquartered in Seongnam-si, South Korea.
Aptamer Sciences Inc
| Country | South Korea |
| Founded | 2011 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Dongil Han |
Contact Details
Address: 3-301, (Sampyeong-dong Pangyo seven venture Valley1) Seongnam-si, 13487 South Korea | |
| Phone | 82-31-786-0317 |
| Website | aptsci.com |
Stock Details
| Ticker Symbol | 291650 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dongil Han | Chief Executive Officer |
| Hyung-soon Park | Chief Financial Officer |